Maximus Joint Booster is a booster joint supplement that aims to boost the healing effect of UC-II by combining with the world’s patented herbal based anti-inflammation ingredient – Aflapin® (Boswellia serrata gum resin). Aflapin® is a novel synergistic composition derived from Boswellia serrata gum resin (Indian Patent Application No. 2229/CHE/2008). Aflapin is significantly better as an anti-inflammatory agent compared to the Boswellia extracts presently available in the market. A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the efficacy and tolerability in the treatment of osteoarthritis (OA) of the knee (Clinical trial registration number: ISRCTN80793440). At the end of the study, Aflapin conferred clinically and statistically significant improvements in pain scores and physical function scores in OA subjects. Interestingly, significant improvements in pain score and functional ability were recorded as early as 7 days after initiation of the study in the treatment group. Aflapin® is capable of inhibiting cartilage degrading enzyme MMP-3 and has the potential to regulate the inflammatory response by inhibiting ICAM-1.
Purchase this Product and Earn 20.9 Reward Points (RM6.27)
A Combination of World’s best joint ingredient
PETdiatric Laboratories Maximus Joint is developed using UC-II technology, for veterinary usage. New UC-II randomized, double-blind, placebo-controlled study was conducted on healthy subjects. UC-II® provided significant results compared to placebo in increasing joint function. UC-II® consists of undenatured type II collagen, a FDA-notified and published new dietary ingredient (NDI). UC-II® is manufactured in a GMP-certified facility and has been determined GRAS for use in foods and beverages.
Booster for Faster Pain Relief
Indication: For dogs and cats with joint arthritis and osteoarthritis
Dosage: One tablet a day for animal below 40kg
Ingredient: contains Aflapin, UC-II and maltodextrin
Content: 30 tablets
Maximus Joint Booster is suitable for animal that are on first time diagnosed with OA and for animal patient that is shifting from Glucosamine + Chondroitin supplemented to UC-II joint solution.